Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : iPSC-based Cell Therapy
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Preclinical
Sponsor : LocalGlobe
Deal Size : $5.3 million
Deal Type : Financing
Clock.bio Raises $5.3M for Genetic Atlas of Human Rejuvenation Factors
Details : The seed funding enabled clock.bio to generate its Atlas of Rejuvenation Factors across the entire human genome and identified several potential gene therapy targets for rejuvenation.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
October 09, 2024
Lead Product(s) : iPSC-based Cell Therapy
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Preclinical
Sponsor : LocalGlobe
Deal Size : $5.3 million
Deal Type : Financing
LOOKING FOR A SUPPLIER?